Subscribe Us

header ads

Recents

header ads

Life Science Tools Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - October 18, 2022

 According to the research report, the global lifescience tools market size is expected to touch USD 95.68 Billion by 2030, from USD 49.82 Billion in 2021, growing with a significant CAGR of 8.5% from 2022 to 2030. 

Life Science Tools Market Size 2020 to 2027

The life science tools market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global life science tools market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global life science tools market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global life science tools market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link https://www.precedenceresearch.com/sample/1064

 Report Scope of the Life Science Tools Market

Report HighlightsDetails
Market SizeUSD 95.68 Billion by 2027
Growth RateCAGR of 8.5% from 2021 to 2027
Fastest Growing MarketAsia Pacific
Largest MarketNorth America
Base Year2021
Forecast Period2021 to 2027
Segments CoveredTechnology, Product, End User, Region

This study covers a detailed segmentation of the global life science tools market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global life science tools market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Agilent Technologies
  • Becton, Dickinson and Company
  • Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • Qiagen N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientif

Market Segmentation

 By Technology

  • Genomic Technology
  • Cell Biology Technology
  • Proteomics Technology
  • Lab Supplies & Technologies
  • Other Analytical & Sample Preparation Technology

By Product

  • NGS
  • Sanger Sequencing
  • Nucleic Acid Preparation
  • Nucleic Acid Microarray
  • PCR & qPCR
  • Flow Cytometry
  • Mass Spectrometry
  • Separation Technologies
  • Electron Microscopy
  • NMR
  • Others

By End-User

  • Biopharmaceutical Company
  • Government & Academic
  • Industry
  • Health Care
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Research Methodology

The research methodology adopted by analysts for compiling the global life science tools market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global life science tools market.

TABLE OF CONTENT

    Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Technology Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Life Science Tools Market, By Product

7.1. Life Science Tools Market, by Product Type, 2020-2027
7.1.1. NGS
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Sanger Sequencing
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Nucleic Acid Preparation
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Nucleic Acid Microarray
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. PCR & qPCR
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Flow Cytometry
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Mass Spectrometry
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Separation Technologies
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Electron Microscopy
7.1.9.1. Market Revenue and Forecast (2016-2027)
7.1.10. NMR
7.1.10.1. Market Revenue and Forecast (2016-2027)
7.1.11. Others
7.1.11.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Life Science Tools Market, By End-User

8.1. Life Science Tools Market, by End-User, 2020-2027
8.1.1. Biopharmaceutical Company
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Government & Academic
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Industry
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Health Care
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Life Science Tools Market, By Technology

9.1. Life Science Tools Market, by Technology, 2020-2027
9.1.1. Genomic Technology
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Cell Biology Technology
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Proteomics Technology
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Lab Supplies & Technologies
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Other Analytical & Sample Preparation Technology
9.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Life Science Tools Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Technology (2016-2027)

Chapter 11. Company Profiles

11.1. Agilent Technologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hoffmann-La Roche Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-Rad Laboratories, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bruker Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hitachi, Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Illumina, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Oxford Instruments plc
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Qiagen N.V.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Shimadzu Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Thermo Fisher Scientific, Inc.
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. ZEISS International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Tags:

Post a Comment

0 Comments